Bischofberger Norbert W
- SEC CIK
- 0001190273
No open-market purchases or sales filed in the past year.
Current role at each company
- VIR Vir Biotechnology, Inc.Directoras of May 28, 2026
- KRON Kronos Bio, Inc.Director, 10% Owneras of Jun 20, 2025
- MORF Morphic Holding, Inc.Directoras of Aug 20, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bischofberger Norbert W as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
KRON Kronos Bio, Inc.
Director, 10% Owner5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2024 (view filing) | Jun 27-28 | 4 days | Bischofberger Norbert WPRESIDENT & CEO | PPurchase | +615.5K | $1.20 | +$736.5K | +6.0%10.8M after | 2 lots |
| Jun 12, 2024 (view filing) | Jun 10-12 | 2 days | Bischofberger Norbert WPRESIDENT & CEO | PPurchase | +3.01M | $1.04 | +$3.12M | +68.8%7.38M after | 3 lots |
| Nov 17, 2023 (view filing) | Nov 15-17 | 2 days | Bischofberger Norbert WPresident & CEO | PPurchase | +1.73M | $0.8462 | +$1.46M | +213.8%2.54M after | 3 lots |
| May 19, 2022 (view filing) | May 17-19 | 2 days | Bischofberger Norbert WPresident & CEO | PPurchase | +597.1K | $3.77 | +$2.25M | +281.0%809.6K after | 3 lots |
| Dec 8, 2021 (view filing) | Dec 6 | 2 days | Bischofberger Norbert WPresident & CEO | PPurchase | +14.4K | $12.09 | +$173.6K | +7.2%212.5K after |